ARCHIVES

Workshop concludes HPV Vaccines Would Be Valuable, Feasible

This article is from The Cancer Letter archive.

Vol. 14 No. 15 | April 8, 1988

Download PDF Visit The Full Archive

Related Articles

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974

Cancer Advocacy: March On Washington Scheduled For September 1998

October 31, 1997

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

August 3, 2001

OSI “Front Line Office” In Probes Of Scientific Misconduct, Kimes Tells NCAB

October 13, 1989